Skip to main content
Log in

Outcome of Index Pregnancy in Women with Recurrent Pregnancy Loss (RPL)

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Background

Recurrent pregnancy loss (RPL) is encountered in 2–5% of Obstetric population and in 50% the cause is unknown and hence it is a challenging situation for the Obstetrician to manage such women. This study was undertaken with the objectives of finding out the causes of RPL, comparing the outcome of index pregnancy between unknown RPL and known RPL and to study the pregnancy outcome with thromboprophylaxis in women with unknown RPL.

Methods

Prospective observational study involving 323 women was undertaken in a tertiary care Institute South India. Women with two or more pregnancy losses without any live birth were included after ethical clearance and were investigated including thrombophilia screening. SSPS version 20 was used for statistical analysis. Comparison of pregnancy outcomes was determined with binomial test of proportions and pregnancy outcome in unknown RPL was calculated by Fisher’s exact test or Chi-square test.

Results

The common etiological factors were Thrombophilias (33%), followed by endocrine causes. There was no difference in miscarriage rates and live birth rates but IUGR, Stillbirth and perinatal deaths were significantly more in women with known RPL after interventions. In unknown RPL thromboprophylaxis with combination of aspirin, enoxaparin or progesterone resulted in significantly more term birth rates (93%).

Conclusion

Thrombophilias were found to be the most common cause in this cohort of Indian women. In women with unknown RPL, thromboprophylaxis with Aspirin alone results in high incidence of preterm birth. Aspirin combined with Enoxaparin and or Progesterone achieves high live birth rate of term foetuses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vora S, Shetty S, Salvi V, et al. Thrombophilia and unexplained pregnancy loss in Indian patients. Natl Med J India. 2008;21(3):116–9 (PMID: 19004141).

    PubMed  Google Scholar 

  2. Kandrop S, Di NM, Goddijn M, et al. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database Syst Rev. 1996;2009:CD004734.

    Google Scholar 

  3. NyboAnderson AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;32:1708–12. https://doi.org/10.1136/bmj.322.7283.429 (PMID: 11179146; PMCID: PMC1119646).

    Article  Google Scholar 

  4. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic Karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73(2):300–4. https://doi.org/10.1016/s0015-0282(99)00495-1 (PMID: 10685533).

    Article  CAS  PubMed  Google Scholar 

  5. Magnus MC, Wilcox AJ, Morken N, et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https://doi.org/10.1136/bmj.l869.

    Article  PubMed  PubMed Central  Google Scholar 

  6. The ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;20018(2):004. https://doi.org/10.1093/hropen/hoy004.

    Article  Google Scholar 

  7. Ford HB, Schust DJ. Recurrent pregnancy loss, etiology, diagnosis and therapy. Rev Obstet Gynaecol. 2009;2(2):76–83 (PMID: 19609401; PMCID: PMC2709325).

    Google Scholar 

  8. Brown R, Gagnon R, Delisle M-F, et al. Cervical insufficiency and cervical cerclage. J Obstet Gynaecol Can. 2013;35(12):1115–27 (PMID: 24405880).

    Article  Google Scholar 

  9. Homer HA, Li TC, Cook ID. The septate Uterus: a review of management and reproductive outcome. Fertil Steril. 2000;73:1–14. https://doi.org/10.1016/s0015-0282(99)00480-x (PMID: 10632403).

    Article  CAS  PubMed  Google Scholar 

  10. Salim R, Regan L, Woelfer B, et al. A comparative study of the morphology of congenital uterine anomalies in women with and without history of recurrent first trimester miscarriage. Hum Reprod. 2003;18:162–6. https://doi.org/10.1093/humrep/deg030 (PMID: 12525460).

    Article  CAS  PubMed  Google Scholar 

  11. Saravelos HS, Yan J, Rehmani H, et al. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod. 2011;26(12):3274–9. https://doi.org/10.1093/humrep/der293.

    Article  PubMed  Google Scholar 

  12. March CM. Asherman’s syndrome. Semin Reprod Med. 2011;29(2):83–94. https://doi.org/10.1055/s-0031-1272470 (Epub 2011 Mar 24 PMID: 21437822).

    Article  PubMed  Google Scholar 

  13. Rao VR, Lakshmi A, Sadhanani MD. Prevalence of hypothyroidism in recurrent pregnancy loss in first trimester. Indian J Med Sci. 2008;62(9):357–61. https://doi.org/10.4103/0019-5359.43122 (PMID: 18923214).

    Article  PubMed  Google Scholar 

  14. Rushworth FH, Backos M, Rai R, et al. Prospective pregnancy outcome in untreated recurrent miscarries with thyroid antibodies. Hum Reprod. 2000;15(7):1637–9. https://doi.org/10.1093/humrep/15.7.1637 (PMID: 10875881).

    Article  CAS  PubMed  Google Scholar 

  15. Bliddal S, Feldt-Rasmussen U, Rasmusssn AK, et al. Thyroid peroxidase antibodies and prospective live birth rate: a cohort study of women with recurrent pregnancy loss. Thyroid. 2019;29(10):1465–74. https://doi.org/10.1089/thy.2019.0077 (Epub 2019 Sep 24 PMID: 31407629).

    Article  CAS  PubMed  Google Scholar 

  16. Rai R, Backos M, Rushworth F, et al. Polycystic ovaries and recurrent miscarriage—a reappraisal. Hum Reprod. 2000;15(612–5):13. https://doi.org/10.1093/humrep/15.3.612 (PMID: 10686206).

    Article  Google Scholar 

  17. Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001;75(1):46–52. https://doi.org/10.1016/s0015-0282(00)01666-6 (PMID: 11163815).

    Article  CAS  PubMed  Google Scholar 

  18. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524–9. https://doi.org/10.1210/jcem.87.2.8207.

    Article  CAS  PubMed  Google Scholar 

  19. Visser J, Ulander VM, Helmerhorst FM, et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial. Thromb Haemost. 2011;105(2):295–301. https://doi.org/10.1160/TH10-05-0334 (Epub 2010 Nov 23. PMID: 21103659).

    Article  CAS  PubMed  Google Scholar 

  20. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 1996;2008(2):CD003511 (PMID: 24173668.).

    Google Scholar 

  21. Oates-Whitehead RM, Haas DM, Carrier JA. Progestogen for preventing miscarriage. Cochrane Database Syst Rev. 1996;2003(4):CD003511 (PMID: 24173668).

    Google Scholar 

  22. Hussain M, El-Hakim S, Cahill DJ. Progesterone supplementation in women with otherwise unexplained recurrent miscarriages. J Hum Reprod Sci. 2012;5(3):248–51. https://doi.org/10.4103/0974-1208.106335 (PMID: 23533097; PMCID: PMC3604830).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Jivraj S, Anstie B, Cheong Y-S. Obstetric and Neonatal outcome in women with history of recurrent miscarriage: a cohort study. Human Reprod. 2001;16:102–6. https://doi.org/10.2147/IJWH.S264229.

    Article  CAS  Google Scholar 

  24. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–11. https://doi.org/10.1016/j.fertnstert.2012.06.048 (Epub 2012 Jul 24 PMID: 22835448).

    Article  Google Scholar 

Download references

Funding

There is no funding from any source for the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paapa Dasari.

Ethics declarations

Conflict of interest

There is no conflicts of interest.

Ethical statement

The Research involved Human participants and ethical approval was obtained from the Institute and informed consent was taken from the Subjects of the study. The manuscript is solely submitted to the Journal of Obstetrics and Gynaecology of India. The work is original and not published elsewhere and not split in to any parts and submitted elsewhere. Oral presentation was done in World congress FIGO- Rio. Data was processed and results as per the standards and there is no fabrication of results. The study was approved the Institute Ethics committee and was performed in line with the principles of the Declaration of Helsinki. Human Studies (IEC/SC/2012/4/152. Consent was obtained from all the subjects who participated in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Paapa Dasari is the Professor, Department of OBGY, JIPMER, Pondicherry-06; Suganya G is the Assistant Professor, Department of OBGY, KMCH-IHSR, Coimbatore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dasari, P., Suganya, G. Outcome of Index Pregnancy in Women with Recurrent Pregnancy Loss (RPL). J Obstet Gynecol India 72 (Suppl 1), 152–158 (2022). https://doi.org/10.1007/s13224-021-01598-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-021-01598-4

Keywords

Navigation